ARCUTIS BIOTHERAPEUTICS, INC. (ARQT)

SEC filing

ARCUTIS BIOTHERAPEUTICS, INC.

ARQT · CIK 1787306

4 · Aug 28, 2026 · Curran Terrie sold 38.20K shares at $25.03/share ($956.1K); exercised options for 38.20K shares

Curran Terrie sold 38.20K shares at $25.03/share ($956.1K); exercised options for 38.20K shares

FORM 4

xslF345X06/wk-form4_1787953199.xmlSEC.gov

Graphics and non-inline formats (not embedded below).